Leflunomide/hydroxychloroquine combination therapy targets type i ifn-associated proteins in patients with sjogren's syndrome that allow prediction and monitoring of clinical response
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要